Is there any potential link among caspase-8, p-p38 MAPK and bcl-2 in clear cell renal cell carcinomas? A comparative immunohistochemical analysis with clinical connotations
Open Access
- 1 January 2009
- journal article
- Published by Springer Nature in Diagnostic Pathology
- Vol. 4 (1) , 7
Abstract
Clear cell renal cell carcinomas (ccRCCs) constitute the most common renal carcinomas, characterized by a relatively aggressive clinical course. Thus, scientific research is targeting towards the identification of immunohistochemical and molecular markers that could be useful regarding diagnosis, appropriate therapy and prediction of prognosis. In the present study we assessed and correlated the expression of caspase-8, phosphorylated p38 mitogen-activated protein kinase (p-p38) and bcl-2 protein with histopathological features and clinical outcome of 27 patients with ccRCCs.Keywords
This publication has 35 references indexed in Scilit:
- Caspase-8 and its inhibitors in RCCs in vivo: the prominent role of ARCApoptosis, 2008
- Enhancement of Death Receptor 4 Mediated Apoptosis and Cytotoxicity in Renal Cell Carcinoma Cells by Subtoxic Concentrations of DoxorubicinJournal of Urology, 2007
- Inhibition of bcl-2 Enhances the Efficacy of Chemotherapy in Renal Cell CarcinomaEuropean Urology, 2005
- Caspase-8 sumoylation is associated with nuclear localizationOncogene, 2005
- Impact of frequent Bcl-2 expression on better prognosis in renal cell carcinoma patientsBritish Journal of Cancer, 2004
- Apoptosis induction in renal cell carcinoma by TRAIL and γ-radiation is impaired by deficient caspase-9 cleavageBritish Journal of Cancer, 2003
- Cell proliferation and apoptosis with bcl-2 expression in renal cell carcinomaUrology, 2000
- Systemic therapy for renal cell carcinoma.2000
- BCL-2 family members and the mitochondria in apoptosisGenes & Development, 1999
- Expression of Bcl-2, p53 Oncoprotein, and Proliferating Cell Nuclear Antigen in Renal Cell CarcinomaEuropean Urology, 1999